Cited by 392interferon and immune responsesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

Open access

Cameron, Mark J., Ran, Longsi, Xu, Luoling, Danesh, Ali, Bermejo-Martin, Jesus F., Cameron, Cheryl M., Muller, Matthew P., Gold, Wayne L., Richardson, Susan E., Poutanen, Susan M., Willey, Barbara M., DeVries, Mark E., Fang, Yuan, Seneviratne, Charit, Bosinger, Steven E., Persad, Desmond, Wilkinson, Peter, Greller, Larry D., Somogyi, Roland, Humar, Atul, Keshavjee, Shaf, Louie, Marie, Loeb, Mark B., Brunton, James, McGeer, Allison J., the Canadian SARS Research Network, Kelvin, David J.·2007·Journal of Virology

DOI 10.1128/jvi.00527-07PMC PMC1951379

Open this paper in CoChat — free account

Abstract

It is not understood how immune inflammation influences the pathogenesis of severe acute respiratory syndrome (SARS). One area of strong controversy is the role of interferon (IFN) responses in the natural history of SARS. The fact that the majority of SARS patients recover after relatively moderate illness suggests that the prevailing notion of deficient type I IFN-mediated immunity, with hypercytokinemia driving a poor clinical course, is oversimplified. We used proteomic and genomic technology to systematically analyze host innate and adaptive immune responses of 40 clinically well-described patients with SARS during discrete phases of illness from the onset of symptoms to discharge or a fatal outcome. A novel signature of high IFN-α, IFN-γ, and IFN-stimulated chemokine levels, plus robust antiviral IFN-stimulated gene (ISG) expression, accompanied early SARS sequelae. As acute illness progressed, SARS patients entered a crisis phase linked to oxygen saturation profiles. The majority of SARS patients resolved IFN responses at crisis and expressed adaptive immune genes. In contrast, patients with poor outcomes showed deviated ISG and immunoglobulin gene expression levels, persistent chemokine levels, and deficient anti-SARS spike antibody production. We contend that unregulated IFN responses during acute-phase SARS may culminate in a malfunction of the switch from innate immunity to adaptive immunity. The potential for the use of the gene signatures we describe in this study to better assess the immunopathology and clinical management of severe viral infections, such as SARS and avian influenza (H5N1), is therefore worth careful examination.

Integrity signals

Registry

Crossref · 10.1128/jvi.00527-07

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217

Flagged first, then by citations

Show all 59 references

Sorted by citations

Items 101–200 of 392

Multiple CD4+ T Cell Subsets Produce Immunomodulatory IL-10 During Respiratory Syncytial Virus Infection
Weiss, K. A., Christiaansen, A. F., Fulton, R. B., Meyerholz, D. K., & Varga, S. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100764 · Cited by 104
Modeling host responses in ferrets during A/California/07/2009 influenza infection
Rowe, T., Leon, A. J., Crevar, C. J., Carter, D. M., Xu, L., Ran, L., Yuan, F., Cameron, C., Cameron, M. J., Banner, D., et al. (2010) · Virology · doi:10.1016/j.virol.2010.02.020 · Cited by 103
Self-citation
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
Elemam, N. M., Talaat, I. M., & Maghazachi, A. A. (2022) · Viruses · doi:10.3390/v14112445 · Cited by 108
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
Tse, L. V., Meganck, R. M., Graham, R. L., & Baric, R. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00658 · Cited by 101
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Radvák, P., Kwon, H., Košíková, M., Ortega‐Rodriguez, U., Xiang, R., Phue, J., Shen, R., Rozzelle, J., Kapoor, N., Rabara, T. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26803-w · Cited by 95
Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome
Liu, M.-M., Lei, X.-Y., Yu, H., Zhang, J.-Z., & Yu, X.-J. (2017) · Virology Journal · doi:10.1186/s12985-016-0677-1 · Cited by 84
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
Lutz, C. M., Maher, L. A., Lee, C., & Kang, W. (2020) · Human Genomics · doi:10.1186/s40246-020-00272-6 · Cited by 95
Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity
Channappanavar, R., & Perlman, S. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144115 · Cited by 94
Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus
Zhao, G., Jiang, Y., Qiu, H., Tongtong, G., Zeng, Y., Guo, Y., Yu, H., Li, J., Kou, Z., Du, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145561 · Cited by 90
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
Iroegbu, J. D., Ifenatuoha, C. W., & Ijomone, O. M. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04469-4 · Cited by 92
Enfermedades Infecciosas y Microbiología Clínica
Viasus, D., Antón, A., Pumarola, T., & Carratalà, J. (2016) · Cited by 90
Distinct Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury Pathways in Two Different Nonhuman Primate Species
Smits, S. L., van den Brand, J. M. A., de Lang, A., Leijten, L. M. E., van IJcken, W. F. J., van Amerongen, G., Osterhaus, A. D. M. E., Andeweg, A. C., & Haagmans, B. L. (2011) · Journal of Virology · doi:10.1128/jvi.02395-10 · Cited by 90
COVID-19: Inflammatory Profile
Wang, Y., & Perlman, S. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-012417 · Cited by 93
Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients
Arankalle, V. A., Lole, K. S., Arya, R. P., Tripathy, A. S., Ramdasi, A. Y., Chadha, M., Sangle, S., & Kadam, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013099 · Cited by 89
Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
Kumar, S., Nyodu, R., Maurya, V. K., & Saxena, S. K. (2020) · Medical virology · doi:10.1007/978-981-15-4814-7_5 · Cited by 90
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Mirzaei, R., Mahdavi, F., Badrzadeh, F., Hosseini‐Fard, S. R., Heidary, M., Jeda, A. S., Mohammadi, T., Roshani, M., Yousefimashouf, R., Keyvani, H., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107204 · Cited by 83
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Yasui, F., Kohara, M., Kitabatake, M., Nishiwaki, T., Fujii, H., Tateno, C., Yoneda, M., Morita, K., Matsushima, K., Koyasu, S., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.005 · Cited by 83
Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice
Nagata, N., Iwata, N., Hasegawa, H., Fukushi, S., Harashima, A., Sato, Y., Saijo, M., Taguchi, F., Morikawa, S., & Sata, T. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071060 · Cited by 83
Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)
McIntosh, K., & Perlman, S. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00157-0 · Cited by 84
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
Prete, M., Favoino, E., Catacchio, G., Racanelli, V., & Perosa, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093377 · Cited by 82
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
Costagliola, G., Spada, E., & Consolini, R. (2021) · Immunity, Inflammation and Disease · doi:10.1002/iid3.404 · Cited by 81
Role of Autophagy in Lung Inflammation
Painter, J. D., Galle-Treger, L., & Akbari, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01337 · Cited by 79
Advances in the relationship between coronavirus infection and cardiovascular diseases
Zhao, M., Wang, M., Zhang, J., Ye, J., Xu, Y. Q., Wang, Z., Ye, D., Liu, J., & Wan, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110230 · Cited by 83
Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis
Zhao, Y., Zhao, L., Yang, X., & Wang, P. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2021.01.238 · Cited by 74
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
Chau, A. S., Weber, A. G., Maria, N. I., Narain, S., Liu, A., Hajizadeh, N., Malhotra, P., Bloom, O., Marder, G. S., & Kaplan, B. M. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41526 · Cited by 75
SARS-CoV-2: is there neuroinvasion?
McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 72
Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections
Acosta, P. L., Byrne, A. B., Hijano, D. R., & Talarico, L. B. (2020) · Journal of Immunology Research · doi:10.1155/2020/1372494 · Cited by 75
Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients
Liu, F., Ye, S., Zhu, X. J., He, X., Wang, S., Li, Y., Lin, J., Wang, J., Lin, Y., Ren, X., et al. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02583-7 · Cited by 70
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
Pillaiyar, T., & Laufer, S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00335 · Cited by 70
Altered Pathogenesis of Porcine Respiratory Coronavirus in Pigs due to Immunosuppressive Effects of Dexamethasone: Implications for Corticosteroid Use in Treatment of Severe Acute Respiratory Syndrome Coronavirus
Jung, K., Alekseev, K. P., Zhang, X., Cheon, D., Vlasova, A. N., & Saif, L. J. (2007) · Journal of Virology · doi:10.1128/jvi.01702-07 · Cited by 70
Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model
Cameron, M. J., Kelvin, A. A., Leon, A. J., Cameron, C., Ran, L., Xu, L., Chu, Y.-K., Danesh, A., Yuan, F., Li, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045842 · Cited by 68
Self-citation
A novel H1N1 virus causes the first pandemic of the 21st century
Peiris, M. J. S., Tu, W., & Yen, H. (2009) · European Journal of Immunology · doi:10.1002/eji.200939911 · Cited by 67
SARS-CoV-2 Infection of Airway Epithelial Cells
Ryu, G., & Shin, H. (2021) · Immune Network · doi:10.4110/in.2021.21.e3 · Cited by 74
Host gene variability and SARS-CoV-2 infection: A review article
Kaidashev, I., Shlykova, O., Izmailova, O., Torubara, O., Yushchenko, Y. O., Tyshkovska, T., Kyslyi, V., Belyaeva, A., & Maryniak, D. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07863 · Cited by 60
SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation
Chang, Y.-S., Ko, B.-H., Ju, J.-C., Chang, H., Huang, S., & Lin, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093179 · Cited by 64
Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
Clay, C. C., Donart, N., Fomukong, N. G., Knight, J. B., Lei, W., Price, L., Hahn, F. F., Westrienen, J. V., & Harrod, K. S. (2012) · Journal of Virology · doi:10.1128/jvi.06791-11 · Cited by 64
Baricitinib for COVID-19: a suitable treatment? – Authors' reply
Richardson, P. J., Corbellino, M., & Stebbing, J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30270-x · Cited by 64
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
Tincati, C., Cannizzo, E. S., Giacomelli, M., Badolato, R., Monforte, A. D., & Marchetti, G. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580987 · Cited by 61
Expert-Augmented computational drug repurposing identified baricitinib as a treatment for COVID-19
Smith, D. P., Oechsle, O., Rawling, M. J., Savory, E., Lacoste, A. M. B., & Richardson, P. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709856 · Cited by 62
Middle East Respiratory Syndrome Virus Pathogenesis
Singh, S. K. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1584796 · Cited by 61
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome
Borges, R. C., Hohmann, M. S., & Borghi, S. M. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1844195 · Cited by 61
GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection
Foo, C. X., Bartlett, S., Chew, K. Y., Ngo, M. D., Bielefeldt‐Ohmann, H., Arachchige, B. J., Matthews, B., Reed, S., Wang, R., Smith, C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01306-2022 · Cited by 62
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease
Bükülmez, H. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01028-4 · Cited by 59
Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus–Host Interaction and Pathogenesis
Zhang, H., Huanying, Z., Zhu, J., Dong, Q., Wang, J., Fan, H., Chen, Y., Zhang, X., Han, X., Li, Q., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00758 · Cited by 60
Bugs in the system
Menachery, V. D., & Baric, R. S. (2013) · Immunological Reviews · doi:10.1111/imr.12092 · Cited by 57
Role of arachidonic cascade in COVID-19 infection: A review
Ripon, M. A. R., Bhowmik, D. R., Amin, M. T., & Hossain, M. S. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106539 · Cited by 59
Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory Syndrome
Zhang, X., Alekseev, K. P., Jung, K., Vlasova, A. N., Hadya, N., & Saif, L. J. (2008) · Journal of Virology · doi:10.1128/jvi.02190-07 · Cited by 56
COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
Seth, S., Batra, J., & Srinivasan, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00215 · Cited by 56
Highly Pathogenic (H5N1) Avian Influenza Induces an Inflammatory T Helper Type 1 Cytokine Response in the Chicken
Karpala, A. J., Bingham, J., Schat, K. A., Chen, L., Donis, R. O., Lowenthal, J. W., & Bean, A. G. D. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0069 · Cited by 59
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
Bakadia, B. M., He, F., Souho, T., Lamboni, L., Ullah, M. W., Boni, B. O. O., Ahmed, A. A. Q., Mukole, B. M., & Yang, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111008 · Cited by 56
CXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitro
Sidahmed, A. M. E., Leon, A. J., Bosinger, S. E., Banner, D., Danesh, A., Cameron, M. J., & Kelvin, D. J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.002 · Cited by 55
Self-citation
Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
Carter-Timofte, M. E., Jørgensen, S. E., Freytag, M. R., Thomsen, M. M., Andersen, N.-S. B., Al-Mousawi, A., Hait, A. S., & Mogensen, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01606 · Cited by 52
Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation
Danesh, A., Cameron, C. M., León, A. J., Ran, L., Xu, L., Fang, Y., Kelvin, A. A., Rowe, T., Chen, H., Guan, Y., et al. (2011) · Virology · doi:10.1016/j.virol.2010.10.002 · Cited by 51
Self-citation
Implications of COVID-19 in pediatric rheumatology
Batu, E. D., & Özen, S. (2020) · Rheumatology International · doi:10.1007/s00296-020-04612-6 · Cited by 52
Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study
Fernández-Ruiz, M., López-Medrano, F., Asín, M. P. P.-J., de la Calle, G. M., Bueno, H., Caro-Teller, J., Catalán, M., de la Calle, C., García-García, R., Gómez, C., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26308 · Cited by 45
Lymphopenia in Covid-19: A single center retrospective study of 589 cases
Ghizlane, E. A., Merbouh, M., Abderrahim, E. K., Rhalete, A. E., Maarad, M., Alkouh, R., Bouazzaoui, M. A., Bkiyar, H., Abda, N., & Brahim, H. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102816 · Cited by 51
Immunomodulatory effects in the spleen‐injured mice following exposure to titanium dioxide nanoparticles
Sang, X., Fei, M., Sheng, L., Zhao, X., Yu, X., Hong, J., Ze, Y., Gui, S., Sun, Q., Ze, X., et al. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35034 · Cited by 51
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
Singh, D. K., Aladyeva, E., Das, S., Singh, B., Esaulova, E., Swain, A., Ahmed, M., Cole, J., Moodley, C., Mehra, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28315-7 · Cited by 47
Putative Role of Vitamin D for COVID-19 Vaccination
Chiu, S.-K., Tsai, K., Wu, C., Zheng, C., Yang, C., Hu, W., Hou, Y., Lu, K., & Chao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168988 · Cited by 50
Protective and Pathologic Roles of the Immune Response to Mouse Hepatitis Virus Type 1: Implications for Severe Acute Respiratory Syndrome
Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Epping, L. L., Haring, J. S., Varga, S. M., & Harty, J. T. (2009) · Journal of Virology · doi:10.1128/jvi.00355-09 · Cited by 49
Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019
Bowman, E., Cameron, C., Avery, A., Gabriel, J., Kettelhut, A., Hecker, M. T., Sontich, C. U., Tamilselvan, B., Nichols, C. N., Richardson, B., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa744 · Cited by 50
Self-citation
Transcriptomic Analysis Reveals a Mechanism for a Prefibrotic Phenotype in STAT1 Knockout Mice during Severe Acute Respiratory Syndrome Coronavirus Infection
Zornetzer, G. A., Frieman, M. B., Rosenzweig, E., Korth, M. J., Page, C., Baric, R. S., & Katze, M. G. (2010) · Journal of Virology · doi:10.1128/jvi.01130-10 · Cited by 48
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
Quan, C., Li, C., Ma, H., Li, Y., & Zhang, H. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-20 · Cited by 49
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
Ahmed-Hassan, H., Sisson, B., Shukla, R. K., Wijewantha, Y., Funderburg, N. T., Li, Z., Hayes, D., Demberg, T., & Liyanage, N. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01979 · Cited by 47
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
Hirawat, R., Saifi, M. A., & Godugu, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118923 · Cited by 48
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients
Guo, W.-F., Zhang, S., Feng, Y.-H., Liang, J., Zeng, T., & Chen, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1272 · Cited by 46
Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome
Malle, L., Martín-Fernández, M., Buta, S., Richardson, A., Bush, D. S., & Bogunovic, D. (2022) · Immunity · doi:10.1016/j.immuni.2022.09.007 · Cited by 48
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
Kuri, T., Zhang, X., Habjan, M., Martínez‐Sobrido, L., García‐Sastre, A., Yuan, Z., & Weber, F. (2009) · Journal of General Virology · doi:10.1099/vir.0.013599-0 · Cited by 46
Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1–Nup98 Complex to Compete With mRNA Nuclear Export
Li, T., Wen, Y., Guo, H., Yang, T., Yang, H., & Ji, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.813248 · Cited by 45
Autocrine Interferon Priming in Macrophages but Not Dendritic Cells Results in Enhanced Cytokine and Chemokine Production after Coronavirus Infection
Zhou, H., Zhao, J., & Perlman, S. M. (2010) · mBio · doi:10.1128/mbio.00219-10 · Cited by 47
Killer Ig-Like Receptor ( KIR ) Genotype Predicts the Capacity of Human KIR-Positive CD56dim NK Cells to Respond to Pathogen-Associated Signals
Korbel, D. S., Norman, P. J., Newman, K. C., Horowitz, A., Gendzekhadze, K., Parham, P., & Riley, E. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804224 · Cited by 44
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
Johnson, B. S., & Laloraya, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.014 · Cited by 42
Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
Yunis, J., Short, K. R., & Yu, D. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2022.12.008 · Cited by 40
IL-12 RB1 Genetic Variants Contribute to Human Susceptibility to Severe Acute Respiratory Syndrome Infection among Chinese
Tang, F., Liu, W., Zhang, F., Xin, Z.-T., Wei, M.-T., Zhang, P. H., Yang, H., Ly, H., & Cao, W.-C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002183 · Cited by 39
Literature-related discovery: Potential treatments and preventatives for SARS
Kostoff, R. N. (2011) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2011.03.022 · Cited by 38
Activation of Interferon Response Through Toll-Like Receptor 3 Impacts Viral Pathogenesis and Pulmonary Toll-Like Receptor Expression During Respiratory Syncytial Virus and Influenza Infections in the Cotton Rat Sigmodon hispidus Model
Boukhvalova, M. S., Sotomayor, T. B., Point, R. C., Pletneva, L. M., Prince, G. A., & Blanco, J. C. G. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0025 · Cited by 38
Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza
Almansa, R., Antón, A., Ramírez, P., Martín‐Loeches, I., Banner, D., Pumarola, T., Xu, L., Blanco, J., Ran, L., López–Campos, G., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-232 · Cited by 39
Self-citation
COVID‐19 pneumonia in kidney transplant recipients: Focus on immunosuppression management
Chen, T. Y., Farghaly, S., Cham, S. H., Tatem, L. L., Sin, J. H., Rauda, R., Ribisi, M. S., & Sumrani, N. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13378 · Cited by 39
Current COVID-19 treatments: Rapid review of the literature
Dong, Y., Shamsuddin, A., Campbell, H. J., & Τheodoratou, E. (2021) · Journal of Global Health · doi:10.7189/jogh.11.10003 · Cited by 37
SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage
Alonso, A. M., & Diambra, L. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00831 · Cited by 38
Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
Alefishat, E. A., Jelinek, H. F., Mousa, M., Tay, G. K., & AlSafar, H. S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.007 · Cited by 39
Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology
Raha, A. A., Chakraborty, S., Henderson, J. W., Mukaetova-Ladinska, E. B., Zaman, S. H., Trowsdale, J., & Raha‐Chowdhury, R. (2020) · Bioscience Reports · doi:10.1042/bsr20203092 · Cited by 35
Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19
Zhang, J., Zhao, C., & Zhao, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633769 · Cited by 36
Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1
Saleki, K., Banazadeh, M., Miri, N. S., & Azadmehr, A. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0047 · Cited by 37
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
Khalaj‐Hedayati, A. (2020) · Journal of Immunology Research · doi:10.1155/2020/7201752 · Cited by 35
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
Scagnolari, C., Pierangeli, A., Frasca, F., Bitossi, C., Viscido, A., Oliveto, G., Scordio, M., Mazzuti, L., Carlo, D. D., Gentile, M., et al. (2021) · Virus Research · doi:10.1016/j.virusres.2020.198283 · Cited by 35
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
McGee, M. C., August, A., & Huang, W. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5covr0620-306r · Cited by 33
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
Goyal, R., Gautam, R. K., Chopra, H., Dubey, A. K., Singla, R. K., Rayan, R. Α., & Kamal, M. A. (2022) · EXCLI journal · doi:10.17179/excli2022-5355 · Cited by 38
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
O’Connell, P., & Aldhamen, Y. A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1802974 · Cited by 34
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
Amigues, I., Pearlman, A. H., Patel, A. M., Reid, P. D., Robinson, P. C., Sinha, R. R., Kim, A. H. J., Youngstein, T., Jayatilleke, A., & Konig, M. F. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1847084 · Cited by 33
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
Zhang, Y., Chen, Y., & Meng, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577442 · Cited by 34
Roles of Type I and III Interferons in COVID-19
Choi, H., & Shin, E. (2021) · Yonsei Medical Journal · doi:10.3349/ymj.2021.62.5.381 · Cited by 35
Human coronaviruses: Clinical features and phylogenetic analysis
Li, S.-W., & Lin, C. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.007 · Cited by 32
Clinical significance of dynamic monitoring of blood lactic acid, oxygenation index and C-reactive protein levels in patients with severe pneumonia
Liu, W., Peng, L., & Hua, S. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2770 · Cited by 32
Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2
İnandıklıoğlu, N., & Akkoç, T. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_549 · Cited by 32
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
Rappe, J. C. F., Finsterbusch, K., Crotta, S., Mack, M., Priestnall, S. L., & Wack, A. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201631 · Cited by 36
Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis
Albini, A., Calabrone, L., Carlini, V., Benedetto, N., Lombardo, M., Bruno, A., & Noonan, D. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718136 · Cited by 34
Transcriptome sequencing and development of an expression microarray platform for the domestic ferret
Bruder, C. E. G., Yao, S., Larson, F., Camp, J. V., Tapp, R. A., McBrayer, A. C., Powers, N., Valdivia-Granda, W., & Jonsson, C. B. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-251 · Cited by 30
Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 InfectionPreprint
Sultan, I. Y., Howard, S. C., & Tbakhi, A. (2020) · doi:10.21203/rs.3.rs-18714/v1 · Cited by 30

Authors: Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., Willey, B. M., DeVries, M. E., Fang, Y., Seneviratne, C., Bosinger, S. E., Persad, D., Wilkinson, P., Greller, L. D., Somogyi, R., Humar, A., Keshavjee, S., Louie, M., Loeb, M. B., Brunton, J., McGeer, A. J., the Canadian SARS Research Network, & Kelvin, D. J.
Affiliations: University Health Network (CA)
University of Valladolid, Valladolid, Spain
Mount Sinai Hospital (CA)
University of Toronto (CA)
University Health Network, Toronto, Ontario, Canada
Centre Hospitalier de l’Université de Montréal (CA)
Biosystemix, Sydenham, Ontario, Canada
Provincial Laboratory of Public Health (CA)
McMaster University (CA)
ORCID: Cameron, Mark J.
Xu, Luoling
Danesh, Ali
Cameron, Cheryl M.
Muller, Matthew P.
Gold, Wayne L.
Richardson, Susan E.
Poutanen, Susan M.
Bosinger, Steven E.
Wilkinson, Peter
Humar, Atul
Keshavjee, Shaf
Loeb, Mark B.
McGeer, Allison J.
Kelvin, David J.
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 2007-08-15
Volume: 81
Issue: 16
Pages: 8692-8706
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.00527-07
PMC: PMC1951379
OpenAlex: W2049902839
Cited by: 386
References: 59
Citations by year: 2026: 2 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 31 · 2021: 71 · 2020: 121 · 2019: 5 · 2018: 1 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 11 · 2013: 10 · 2012: 10
FWCI: 6.80
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Genome Canada
Ontario Genomics
Ontario Genomics Institute
Canadian Institutes of Health Research
Topics: Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS, interferon, type I interferon, interferon-stimulated genes, interferon-alpha, interferon-gamma, chemokines, innate immunity, adaptive immunity, immunopathology, SARS-CoV, spike antibodies, immunoglobulin genes, gene expression signatures, cytokine storm, H5N1 avian influenza, viral pathogenesis
MeSH terms: Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibody Formation, Female, Humans, Immunity, Innate, Interferons, Male, Middle Aged, Gene Expression, Cytokines, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genomics, Proteomics, Severe Acute Respiratory Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks